[开放获取]    带状疱疹中西医结合诊疗中国专家共识（2026版）

doi:10.35541/cjd.20260045

Abstract

Abstract: 【Abstract】 Herpes zoster is an infectious skin disease caused by the reactivation of the varicella-zoster virus, clinically characterized by skin lesions and neuropathic pain. Both traditional Chinese medicine and Western medicine exhibit respective advantages in the diagnosis and treatment of herpes zoster. Based on current evidence-based research, fully leveraging the strengths of integrated traditional Chinese and Western medicine in the diagnosis and treatment of herpes zoster, and weighing the benefits and risks of diverse interventions, the Chinese Dermatovenerology Society of Integrative Medicine organized relevant experts to formulate a series of recommendations for the diagnosis and treatment of herpes zoster with integrated traditional Chinese and Western medicine, aiming to provide a scientific and reliable reference to support clinicians in their clinical decision-making.

Key words: Herpes zoster, Integrated traditional Chinese medicine and Western medicine, Diagnosis, Therapy, Expert consensus

Chinese Dermatovenerology Society of Integrative Medicine. Chinese expert consensus on diagnosis and treatment of herpes zoster with integrated traditional Chinese and Western medicine （2026 edition）[J]. Chinese Journal of Dermatology,2026,e20260045. doi:10.35541/cjd.20260045

References ［96］

［1］	中国医师协会皮肤科医师分会带状疱疹专家共识工作组, 国家皮肤与免疫疾病临床医学研究中心. 中国带状疱疹诊疗专家共识（2022版）［J］. 中华皮肤科杂志, 2022,55（12）:1033⁃1040. DOI: 10.35541/cjd.20220608.
［2］	Zhang Z, Liu X, Suo L, et al. The incidence of herpes zoster in China: a meta⁃analysis and evidence quality assessment［J］. Hum Vaccin Immunother, 2023,19（2）:2228169. DOI: 10.1080/21645515.2023.2228169.
［3］	艾津旭, 夏祎祺, 朱文辉, 等. 中国人群带状疱疹患病率及影响因素［J］. 中华流行病学杂志, 2025,46（7）:1204⁃1208. DOI: 10.3760/cma.j.cn112338⁃20250203⁃00067.
［4］	中华中医药学会皮肤科分会. 蛇串疮中医诊疗指南（2014年修订版）［J］. 中医杂志, 2015,56（13）:1163⁃1168. DOI: 10. 13288/j.11⁃2166/r.2015.13.022.
［5］	中华医学会皮肤性病学分会, 中国康复医学会皮肤病康复专业委员会, 中国中西医结合学会皮肤性病学分会, 等. 老年带状疱疹诊疗专家共识［J］. 中华皮肤科杂志, 2023,56（2）:97⁃104. DOI: 10.35541/cjd.20220726.
［6］	Gross GE, Eisert L, Doerr HW, et al. S2k guidelines for the diagnosis and treatment of herpes zoster and postherpetic neuralgia［J］. J Dtsch Dermatol Ges, 2020,18（1）:55⁃78. DOI: 10.1111/ddg.14013.
［7］	带状疱疹后神经痛诊疗共识编写专家组. 带状疱疹后神经痛诊疗中国专家共识［J］. 中国疼痛医学杂志, 2016,22（3）:161⁃167. DOI: 10.3969/j.issn.1006⁃9852.2016.03.001.
［8］	中华医学会疼痛学分会, 中华医学会皮肤性病学分会, 中国医师协会疼痛科医师分会, 等. 中国带状疱疹相关性疼痛全程管理指南（2025版）［J］. 中国疼痛医学杂志, 2025,31（8）:561⁃571. DOI: 10.3969/j.issn.1006⁃9852.2025.08.001.
［9］	中国医疗保健国际交流促进会皮肤科分会, 中华医学会皮肤性病学分会老年性皮肤病研究中心. 带状疱疹疫苗预防接种专家共识［J］. 中华医学杂志, 2022,102（8）:538⁃543. DOI: 10.3760/cma.j.cn112137⁃20210828⁃01958.
［10］	中国神经病理性疼痛诊疗指南制订专家组, 中国老年保健协会疼痛病学分会, 程志祥, 等. 中国神经病理性疼痛诊疗指南（2024版）［J］. 中华疼痛学杂志, 2024,20（4）:484⁃508. DOI: 10. 3760/cma.j.cn101658⁃20240813⁃00110.
［11］	国家疼痛专业质控中心神经病理性疼痛专家组, 段宝霖, 樊碧发, 等. 神经病理性疼痛评估与管理中国指南（2024版）［J］. 中国疼痛医学杂志, 2024,30（1）:5⁃14. DOI: 10.3969/j.issn.1006⁃9852.2024.01.003.
［12］	WHO. WHO handbook for guideline development［M］. 2nd ed. Geneva: WHO, 2014:93⁃132.
［13］	卢传坚, 杨克虎. 中西医结合诊疗指南制定手册［M］. 北京: 人民卫生出版社, 2016.
［14］	王瑞平, 李斌. 临床指南和专家共识制定中循证医学证据等级和推荐强度确定方法［J］. 上海医药, 2025,46（8）:26⁃31. DOI: 10.3969/j.issn.1006⁃1533.2025.08.006.
［15］	国家卫生健康委员会, 国家中医药管理局. 水痘诊疗方案（2023年版）［J］. 国际流行病学传染病学杂志, 2024,51（1）:4⁃6. DOI: 10.3760/cma.j.cn331340⁃20240117⁃00013.
［16］	原铭, 赵惠. 中医治疗带状疱疹后遗神经痛的研究进展［J］. 中医学, 2024,13（6）:1370⁃1375. DOI: 10.12677/tcm.2024. 136206.
［17］	王兴旺, 杨慧兰. 带状疱疹抗病毒药物的合理选择［J］. 中华皮肤科杂志, 2023,56（3）:262⁃265. DOI: 10.35541/cjd.2022 0659.
［18］	Degreef H, Famciclovir Herpes Zoster Clinical Study Group. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients［J］. Int J Antimicrob Agents, 1994,4（4）:241⁃246. DOI: 10.1016/0924⁃8579（94）90024⁃8.
［19］	Ono F, Yasumoto S, Furumura M, et al. Comparison between famciclovir and valacyclovir for acute pain in adult Japanese immunocompetent patients with herpes zoster［J］. J Dermatol, 2012,39（11）:902⁃908. DOI: 10.1111/j.1346⁃8138.2012.01584.x.
［20］	Pott Junior H, de Oliveira M, Gambero S, et al. Randomized clinical trial of famciclovir or acyclovir for the treatment of herpes zoster in adults［J］. Int J Infect Dis, 2018,72:11⁃15. DOI: 10.1016/j.ijid.2018.04.4324.
［21］	Machida H, Nishitani M, Watanabe Y, et al. Comparison of the selectivity of anti⁃varicella⁃zoster virus nucleoside analogues［J］. Microbiol Immunol, 1995,39（3）:201⁃206. DOI: 10.1111/j.1348⁃0421.1995.tb02189.x.
［22］	Wassilew SW, Wutzler P, Brivddin Herpes Zoster Study Group. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of a randomized, double⁃blind, multicentered study［J］. Antiviral Res, 2003,59（1）:49⁃56. DOI: 10.1016/s0166⁃3542（03）00065⁃2.
［23］	Yaldiz M, Solak B, Kara RO, et al. Comparison of famciclovir, valaciclovir, and brivudine treatments in adult immunocompetent patients with herpes zoster［J］. Am J Ther, 2018,25（6）:e626⁃e634. DOI: 10.1097/MJT.0000000000000436.
［24］	Chen J, Lei D, Cao P, et al. Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta⁃analysis［J］. J Dermatolog Treat, 2024,35（1）:2355256. DOI: 10.1080/09546634.2024.2355256.
［25］	Peng F, He H, Xia T, et al. Comparison of a one⁃ versus two⁃week treatment with famciclovir upon reductions in pain and occurrence of postherpetic neuralgia in herpes zoster: a randomized open⁃label trial［J］. Infect Drug Resist, 2023,16:721⁃726. DOI: 10.2147/IDR.S385442.
［26］	Xing X, Sun K, Yan M. Delayed initiation of supplemental pain management is associated with postherpetic neuralgia: a retrospective study［J］. Pain Physician, 2020,23（1）:65⁃72.
［27］	Zhang L, Duan A, Li Y, et al. Longdan Xiegan formula as adjuvant therapy for acute herpes zoster: a meta⁃analysis of randomized controlled trials［J］. Dermatol Ther, 2022,35（11）:e15822. DOI: 10.1111/dth.15822.
［28］	周国权. 中医扶正补虚法治疗气血两虚型带状疱疹疗效观察［J］. 广西中医药大学学报, 2015,18（4）:33⁃34.
［29］	张春玉, 罗希, 王蕾, 等. 青黛散外敷在带状疱疹急性期治疗中的临床疗效［J］. 中国麻风皮肤病杂志, 2020,36（12）:750⁃751,759. DOI: 10.12144/zgmfskin202012750.
［30］	陈斌宏. 云南白药外敷治疗带状疱疹60例疗效观察［J］. 中华全科医学, 2012,10（5）:742. DOI: 10.16766/j.cnki.issn.1674⁃4152.2012.05.036.
［31］	沈芳, 杨德刚, 吴娟, 等. 盐酸伐昔洛韦片联合季德胜蛇药片片治疗急性期带状疱疹随机对照临床研究［J］. 上海医药, 2023,44（11）:3⁃6,16. DOI: 10.3969/j.issn.1006⁃1533.2023.11.002.
［32］	王玉琴. 中药内服配合六神丸及绿药膏外敷治疗带状疱疹34例［J］. 中医药导报, 2012,18（11）:49⁃50. DOI: 10.3969/j.issn.1672⁃951X.2012.11.021.
［33］	朱福华. 六神丸与阿昔洛韦治疗老年急性带状疱疹的疗效及安全性比较［J］. 中国医药指南, 2014,12（30）:270⁃271. DOI: 10.15912/j.cnki.gocm.2014.30.202.
［34］	郑桂芳, 陈明, 陈华强. 复方黄柏液湿敷治疗带状疱疹临床疗效［J］. 深圳中西医结合杂志, 2022,32（22）:50⁃53. DOI: 10.16458/j.cnki.1007⁃0893.2022.22.015.
［35］	Zhang J, Mou Q, Wang Z, et al. Comparison of efficacy of acupuncture⁃related therapy in the treatment of herpes zoster: a network meta⁃analysis of randomized controlled trials［J］. Medicine （Baltimore）, 2023,102（39）:e34920. DOI: 10.1097/MD.0000000000034920.
［36］	银子涵, 张琼月, 徐桂兴, 等. 电针夹脊穴疗法与单纯西药治疗带状疱疹疗效及安全性比较的系统评价［J］. 护理研究, 2020,34（16）:2809⁃2819. DOI: 10.12102/j.issn.1009⁃6493. 2020.16.001.
［37］	张春玉, 沈芳, 赖永贤, 等. “药⁃针⁃罐”序贯疗法治疗带状疱疹及预防后遗神经痛的临床研究［J］. 中国中医急症, 2018,27（1）:74⁃76. DOI: 10.3969/j.issn.1004⁃745X.2018.01.023.
［38］	武晓冬, 李彬, 刘保延, 等. 火针治疗带状疱疹临床方案专家共识［J］. 中国针灸, 2025,45（12）:1825⁃1832. DOI: 10.13703/j.0255⁃2930.20250816⁃k0001.
［39］	张艳琳, 吴松, 何晓茹, 等. 毫火针赞刺法治疗肝经郁热型急性期带状疱疹的随机对照试验［J］. 中华中医药杂志, 2025,40（7）:3975⁃3979.
［40］	赖永贤, 陈佳, 沈芳, 等. 无菌揿针治疗带状疱疹后遗神经痛的临床观察［J］. 辽宁中医杂志, 2019,46（6）:1278⁃1280. DOI: 10.13192/j.issn.1000⁃1719.2019.06.050.
［41］	邱岳东. 围刺法联合除湿胃苓汤加减治疗带状疱疹脾虚湿蕴证临床观察［J］. 浙江中医杂志, 2024,59（3）:267. DOI: 10.3969/j.issn.0411⁃8421.2024.03.039.
［42］	冯勇伟, 王朝阳, 李国梁, 等. 刺络拔罐加围刺法对急性期带状疱疹患者疼痛及相关炎性因子水平的影响［J］. 现代中西医结合杂志, 2020,29（21）:2333⁃2336. DOI: 10.3969/j.issn. 1008⁃8849.2020.21.013.
［43］	黄青林, 张沁春, 陈旭龙, 等. 刺络拔罐法配合紫外线照射治疗急性带状疱疹60例［J］. 针灸临床杂志, 2008,24（5）:10⁃11. DOI: 10.3969/j.issn.1005⁃0779.2008.05.005.
［44］	图雅, 张洪凤, 张津津. 刺络拔罐联合氦氖激光治疗51例带状疱疹临床观察［J］. 中国中西医结合皮肤性病学杂志, 2015,14（6）:386⁃387. DOI: 10.3969/j.issn.1672⁃0709.2015.06.019.
［45］	梅雪峰, 罗昭兰. 艾灸治疗带状疱疹疗效观察［J］. 中医临床研究, 2016,8（6）:105⁃106.
［46］	Li L, Xu J, Al⁃Danakh A, et al. Integrated western and traditional Chinese medicine approaches for herpes zoster and post⁃herpetic neuralgia: a narrative review［J］. Drug Des Devel Ther, 2026,20:570847. DOI: 10.2147/DDDT.S570847.
［47］	应华亨. 常规西药配合中药外敷治疗带状疱疹80例的临床疗效［J］. 中国医师进修杂志, 2009,32（24）:46⁃47. DOI: 10. 3760/cma.j.issn.1673⁃4904.2009.24.019.
［48］	赵平丽, 刘建东, 张平. 中西医结合治疗急性期带状疱疹临床观察［J］. 实用中医药杂志, 2015,31（7）:640⁃641,642. DOI: 10. 3969/j.issn.1004⁃2814.2015.07.034.
［49］	Pu J, Li D, Luo X, et al. Wrist⁃ankle acupuncture alleviates pain in the acute phase of herpes zoster: a randomized controlled trial［J］. PLoS One, 2025,20（5）:e0318386. DOI: 10.1371/journal.pone.0318386.
［50］	刘汉山, 丁鹏, 李强, 等. 中医综合疗法治疗急性期带状疱疹的疗效观察［J］. 中国中医急症, 2021,30（9）:1651⁃1653. DOI: 10.3969/j.issn.1004⁃745X.2021.09.039.
［51］	刘星, 樊碧发, 李怡帆, 等. 带状疱疹后神经痛发生的影响因素及临床预测模型构建［J］. 中国疼痛医学杂志, 2022,28（2）:106⁃112. DOI: 10.3969/j.issn.1006⁃9852.2022.02.005.
［52］	Yang F, Yu S, Fan B, et al. The epidemiology of herpes zoster and postherpetic neuralgia in China: results from a cross⁃sectional study［J］. Pain Ther, 2019,8（2）:249⁃259. DOI: 10. 1007/s40122⁃019⁃0127⁃z.
［53］	Zhang D, Lei T, Qin L, et al. Efficacy and safety of crisugabalin （HSK16149） in adults with postherpetic neuralgia: a phase 3 randomized clinical trial［J］. JAMA Dermatol, 2024,160（11）:1182⁃1191. DOI: 10.1001/jamadermatol.2024.3410.
［54］	Gou X, Yu X, Bai D, et al. Pharmacology and mechanism of action of HSK16149, a selective ligand of α2δ subunit of voltage⁃gated calcium channel with analgesic activity in animal models of chronic pain［J］. J Pharmacol Exp Ther, 2021,376（3）:330⁃337. DOI: 10.1124/jpet.120.000315.
［55］	Chen Q, Wu Q, Song R, et al. A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects［J］. Front Pharmacol, 2023,14:1296672. DOI: 10.3389/fphar.2023.1296672.
［56］	Chen L, Qing A, Zhu T, et al. Effect and safety of extracorporeal shockwave therapy for postherpetic neuralgia: a randomized single⁃blind clinical study［J］. Front Neurol, 2022,13:948024. DOI: 10.3389/fneur.2022.948024.
［57］	潘祥会, 盛平卫. 中医药治疗带状疱疹后遗神经痛的方法及其疗效的进展研究［J］. 临床医学进展, 2023,13（6）:10175⁃10181. DOI: 10.12677/ACM.2023.1361424.
［58］	赵娥, 王俊, 李倩, 等. 血府逐瘀汤治疗带状疱疹后遗神经痛疗效的Meta分析［J］. 新疆医科大学学报, 2023,46（3）:390⁃397. DOI: 10.3969/j.issn.1009⁃5551.2023.03.019.
［59］	王平, 王丽, 孟威威. 桃红四物汤加减辅治带状疱疹后遗神经痛气虚血瘀型临床观察［J］. 实用中医药杂志, 2025,41（8）:1634⁃1637. DOI: 10.3969/j.issn.1004⁃2814.2025.08.046.
［60］	吴幼清, 孙清己. 补阳还五汤加减治疗带状疱疹后遗神经痛的临床疗效［J］. 临床合理用药杂志, 2021,14（30）:35⁃37. DOI: 10.15887/j.cnki.13⁃1389/r.2021.30.011.
［61］	Pei W, Zeng J, Lu L, et al. Is acupuncture an effective postherpetic neuralgia treatment? A systematic review and meta⁃analysis［J］. J Pain Res, 2019,12:2155⁃2165. DOI: 10.2147/JPR.S199950.
［62］	郑淇, 沈芳, 唐苏为, 等. 平刺针法治疗带状疱疹后神经痛的临床观察［J］. 中国中医基础医学杂志, 2020,26（11）:1690⁃1692. DOI: 10.3969/j.issn.1006⁃3250.2020.11.033.
［63］	Zhang Y, Liu QN, Haung GF. Observation on therapeutic effect of combined therapy mainly based on acupuncture for postherpetic neuralgia［J］. World J Acupunct Moxibustion, 2013, 23（4）:1⁃5. DOI: 10.1016/S1003⁃5257（14）60001⁃5.
［64］	Simpson C, Dilley A, Viscidi E. 910. Herpes zoster in children: a literature review［J］. Open Forum Infect Dis, 2023, 10（Suppl 2）: ofad500.955. DOI: 10.1093/ofid/ofad500.955.
［65］	李巧芬. 100例儿童带状疱疹中西医结合治疗的临床分析［J］. 中国医药指南, 2013,11（3）:268⁃269. DOI: 10.15912/j.cnki.gocm.2013.03.068.
［66］	Charlier C, Anselem O, Caseris M, et al. Prevention and management of VZV infection during pregnancy and the perinatal period［J］. Infect Dis Now, 2024,54（4）:104857. DOI: 10.1016/j.idnow.2024.104857.
［67］	Hayward K, Cline A, Stephens A, et al. Management of herpes zoster （shingles） during pregnancy［J］. J Obstet Gynaecol, 2018,38（7）:887⁃894. DOI: 10.1080/01443615.2018.1446419.
［68］	刘云, 龚丽萍, 黄港, 等. 火针联合复方黄柏液治疗妊娠期带状疱疹的临床研究［J］. 世界最新医学信息文摘, 2019,19（50）:144,148. DOI: 10.19613/j.cnki.1671⁃3141.2019.50.070.
［69］	王博伟, 郭玉峰. 毫火针排针浅刺联合拔罐治疗妊娠期急性带状疱疹的经验探析［J］. 中国民间疗法, 2022,30（13）:23⁃26. DOI: 10.19621/j.cnki.11⁃3555/r.2022.1309.
［70］	Kong J, Wang H, Liu Y, et al. 14⁃day famciclovir treatment significantly reduces the incidence of postherpetic neuralgia in elderly patients with herpes zoster［J］. J Clin Pharm Ther, 2022,47（11）:1805⁃1810. DOI: 10.1111/jcpt.13769.
［71］	Kim J, Jeon J, Lee HS, et al. Association between the risk for cardiovascular events and antiviral treatment for herpes zoster［J］. Clin Infect Dis, 2021,73（5）:758⁃764. DOI: 10.1093/cid/ciaa1384.
［72］	杨贤平, 张子圣, 刘城鑫, 等. 国医大师禤国维治疗带状疱疹后神经痛经验［J］. 中华中医药杂志, 2020,35（7）:3427⁃3429.
［73］	Tsau PW, Liao MF, Hsu JL, et al. Clinical presentations and outcome studies of cranial nerve involvement in herpes zoster infection: a retrospective single⁃center analysis［J］. J Clin Med, 2020,9（4）:946. DOI: 10.3390/jcm9040946.
［74］	Cohen EJ, Troxel AB, Liu M, et al. Low⁃dose valacyclovir in herpes zoster ophthalmicus: the zoster eye disease randomized clinical trial［J］. JAMA Ophthalmol, 2025,143（4）:269⁃276. DOI: 10.1001/jamaophthalmol.2024.6114.
［75］	戴倩, 陆钰珏, 薛青, 等. Ramsay⁃Hunt综合征的诊断和治疗［J］. 中华全科医师杂志, 2024,23（2）:201⁃204. DOI: 10.3760/cma.j.cn114798⁃20230729⁃00028.
［76］	谢卫, 成蓓, 谢晶辉, 等. 中西医结合治疗眼带状疱疹30例［J］. 皮肤病与性病, 2002,24（1）:19⁃20. DOI: 10.3969/j.issn. 1002⁃1310.2002.01.014.
［77］	李媛媛, 王书红, 王杰, 等. 中西医结合治疗眼部带状疱疹30例临床观察［J］. 河北中医, 2015,37（4）:536⁃537,538. DOI: 10.3969/j.issn.1002⁃2619.2015.04.021.
［78］	苏礼潮, 苏礼和, 张伟. 中西医结合治疗眼部带状疱疹疗效观察［J］. 中国中医眼科杂志, 2000,10（2）:114. DOI: 10.3969/j.issn.1002⁃4379.2000.02.029.
［79］	张蓥, 赵媛. 中西医结合治疗耳带状疱疹26例临床分析［J］. 中国中西医结合耳鼻咽喉科杂志, 2016,24（2）:128⁃130. DOI: 10.16542/j.cnki.issn.1007⁃4856.2016.02.017.
［80］	杨秀山. 中西医结合治疗耳带状疱疹30例疗效分析［J］. 中国中西医结合耳鼻咽喉科杂志, 2007,15（3）:211,208. DOI: 10.3969/j.issn.1007⁃4856.2007.03.017.
［81］	刘启兵, 梅贤文. 龙胆泻肝汤治疗会阴部带状疱疹26例［J］. 浙江中医杂志, 2013,48（12）:866.
［82］	王丽丽, 马祖彬. 针刺治疗会阴肛周带状疱疹并发二便障碍案［J］. 中医外治杂志, 2016,25（3）:35. DOI: 10.3969/j.issn. 1006⁃978X.2016.03.021.
［83］	Dong QP, Li SJ. Ultrasound combined with DSA⁃guided pulsed radiofrequency for perineal herpes zoster pain management: clinical outcomes and complications［J］. Front Med （Lausanne）, 2024,11:1442199. DOI: 10.3389/fmed.2024.1442199.
［84］	Koshy E, Mengting L, Kumar H, et al. Epidemiology, treatment and prevention of herpes zoster: a comprehensive review［J］. Indian J Dermatol Venereol Leprol, 2018,84（3）:251⁃262. DOI: 10.4103/ijdvl.IJDVL_1021_16.
［85］	Breton G, Fillet AM, Katlama C, et al. Acyclovir⁃resistant herpes zoster in human immunodeficiency virus⁃infected patients: results of foscarnet therapy［J］. Clin Infect Dis, 1998,27（6）:1525⁃1527. DOI: 10.1086/515045.
［86］	Wang X, Shi H, Tang S, et al. Comparative case series of herpes zoster in older immunocompromised Chinese adults: clinical, immunological, and treatment profiles in four cases over 60［J］. Infect Drug Resist, 2025,18:4513⁃4525. DOI: 10.2147/IDR.S531066.
［87］	Feng M, Zhang J, Zhang G. Case report: relapsed disseminated cutaneous herpes zoster successfully treated with brivudine［J］. Eur J Inflamm, 2023,21:1⁃5. DOI: 10.1177/1721727X231209827.
［88］	Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America［J］. Clin Infect Dis, 2008,47（3）:303⁃327. DOI: 10.1086/589747.
［89］	顾婧, 沈咏慧, 魏颖楠, 等. 水痘-带状疱疹病毒脑膜炎/脑膜脑炎患者临床特征及预后因素分析［J］. 浙江临床医学, 2024,26（6）:852⁃854.
［90］	Lal H, Cunningham AL, Godeaux O, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults［J］. N Engl J Med, 2015,372（22）:2087⁃2096. DOI: 10.1056/NEJMoa 1501184.
［91］	Cunningham AL, Lal H, Kovac M, et al. Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older［J］. N Engl J Med, 2016,375（11）:1019⁃1032. DOI: 10.1056/NEJMoa 1603800.
［92］	Strezova A, Díez Domingo J, Cunningham AL, et al. Final analysis of the ZOE⁃LTFU trial to 11 years post⁃vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications［J］. EClinicalMedicine, 2025,83:103241. DOI: 10.1016/j.eclinm.2025.103241.
［93］	Alexandra Echeverria Proano D, Zhu F, Sun X, et al. Efficacy, reactogenicity, and safety of the adjuvanted recombinant zoster vaccine for the prevention of herpes zoster in Chinese adults ≥ 50 years: a randomized, placebo⁃controlled trial［J］. Hum Vaccin Immunother, 2024,20（1）:2351584. DOI: 10.1080/21645515. 2024.2351584.
［94］	Wang S, Jin P, Quan Y, et al. Efficacy and safety of a China⁃developed live attenuated herpes zoster vaccine in Chinese healthy adults aged 40 years and older: a multicentre, randomized, double⁃blind, placebo⁃controlled, phase 3 clinical trial［J］. Clin Microbiol Infect, 2026,32（1）:128⁃136. DOI: 10. 1016/j.cmi.2025.09.009.
［95］	Dooling KL, Guo A, Patel M, et al. Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines［J］. MMWR Morb Mortal Wkly Rep, 2018,67（3）:103⁃108. DOI: 10.15585/mmwr.mm6703a5.
［96］	Public Health Agency of Canada. Herpes zoster （shingles） vaccine: Canadian Immunization Guide［EB/OL］.（2025⁃05⁃14）［2026⁃01⁃19］.https://www.canada.ca/en/public⁃health/services/publications/healthy⁃living/canadian⁃immunization⁃guide⁃part⁃4⁃active⁃vaccines/page⁃8⁃herpes⁃zoster⁃（shingles）⁃vaccine.html?wbdisable=true.

[1]	Expert Group on the “Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma （ edition）”. Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(8): 728-737.
[2]	Chinese Society of Dermatology, China Dermatologist Association. Chinese guideline for the diagnosis and treatment of cutaneous squamous cell carcinoma （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(8): 703-716.
[3]	Writing Committee Expert Group on “Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （ edition）”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(8): 717-727.
[4]	Li Yanhong, Jiang Kun, Wu Zhuoxuan, Zhang Jianlan, Fang Meizhen, Liu Shuting, Wang Linlin, Hu Lei, Zhou Xiaoyong, Chen Liuqing, Chen Jinbo. Analysis of 18 cases of cutaneous adverse reactions associated with programmed death-1 inhibitors [J]. Chinese Journal of Dermatology, 2026, 59(8): 783-787.
[5]	He Qing, Zhang Tao, Wang Xiuli, Gao Xinghua, Chen Hongduo, Liu Min, Qi Ruiqun. Biomarkers associated with malignant progression of actinic keratosis [J]. Chinese Journal of Dermatology, 2026, 59(7): 687-690.
[6]	Wei Jin¹, Yan Huiwen¹, Zhang Jianzhong², Lun Wenhui¹. Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis complicated by HIV infection: a clinical observation of 10 cases [J]. Chinese Journal of Dermatology, 2026, 59(7): 671-674.
[7]	Wang Linlin, Cao Lijuan, Chen Liuqing, Li Dongsheng, Hu Yanyan. Efficacy and safety of hemoporfin-mediated photodynamic therapy for port-wine stains on the extremities: a retrospective analysis [J]. Chinese Journal of Dermatology, 2026, 59(7): 637-644.
[8]	Zhang Guolong, Zhao Zijun. Aminolevulinic acid-based photodynamic therapy for cutaneous squamous cell carcinoma: current status, challenges, and perspectives [J]. Chinese Journal of Dermatology, 2026, 59(7): 626-631.
[9]	Hu Yu, Lu Yan, Chen Kun, Gu Heng. Standardization, precision, and full-cycle management: interpretation of Specifications for the Management of Vitiligo Patients Undergoing Home Phototherapy [J]. Chinese Journal of Dermatology, 2026, 59(7): 632-636.
[10]	Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline for the clinical application of narrowband ultraviolet B phototherapy in dermatology （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(7): 595-610.
[11]	Photodynamic Therapy Research Cooperative Group, Chinese Society of Dermatology, Chinese Association of Rehabilitation Dermatology & Photodynamic Therapy, Photomedicine Therapeutic Equipment Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Guideline for the clinical application of aminolevulinic acid-based photodynamic therapy in the treatment of condyloma acuminatum （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(7): 611-618.
[12]	Pediatric Dermatology Group, Chinese Society of Dermatology, Dermatology Group, Chinese Pediatric Society, Chinese Medical Association, Pediatric Group, Chinese Association of Rehabilitation Dermatology, Atopic Dermatitis Group, Chinese Association of Rehabilitation Dermatology, Pediatric Dermatology Group, China Dermatologist Association, Dermatology Group, the Society of Pediatrics, Chinese Medical Doctor Association. Chinese consensus on the prevention, treatment, and management of atopic dermatitis in children（2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(6): 487-504.
[13]	Du Xinran, Wang Xinhe, Li Siyu, Chen Moan, Yuan Shaojie, Yan Ran, Cheng Linyan, Guo Wanjun, Wang Yi, Li Fulun. Development and evaluation of a diagnostic scale for atopic dermatitis with the syndrome of wind dryness due to blood deficiency [J]. Chinese Journal of Dermatology, 2026, 59(6): 540-546.
[14]	Li Wei¹, Yao Xu². Research on atopic dermatitis in China: current status and future perspectives [J]. Chinese Journal of Dermatology, 2026, 59(6): 505-511.
[15]	Sun Songpeng, Long Junhong, Cao Bo, Xu Yue, Zhang Xiang′an, Cao Hui, Xie Jun, Gui Ping, Sun Xiaojun, Zhang Bo, Xu Zhijie, Li Jin′an, Wang Zhigang, Wu Wei, Yang Huiju, Wei Ping, Liu Congcong, Shen Qingbo, Yu Fan, Chu Hongchuan, Zhou Yangyang, Liu Jiaxin, Liu Yan, Huo Xingxiao, Chen Hang, Jing Tao, Gao Jing, Wang Yanxun, Wang Rui, Li Zhenyu, Zhang Shuxin. Efficacy and safety of Fuzhiqing ointment versus triamcinolone acetonide and econazole nitrate cream in the treatment of chronic perianal eczema: a multicenter, randomized, double-blind, controlled, equivalence trial [J]. Chinese Journal of Dermatology, 2026, 59(6): 564-570.

Chinese expert consensus on diagnosis and treatment of herpes zoster with integrated traditional Chinese and Western medicine （2026 edition）

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［96］

Related Articles 15

Metrics

Comments

Recommended 0